Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 400-404

  Wu, Zhiyuan ^a   Liu, Bin ^a   Cailing, E ^a,b   Liu, Jie ^a   Zhang, Qingyu ^a   Liu, Juntao ^c   Chen, Nianping ^a   Chen, Rongyi ^a   Zhu, Runzhi ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

A375; Caspase 3; P53; Resveratrol; SK MEL 31

Indexed keywords

CASPASE 3; CASPASE 9; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RESVERATROL; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MELANOMA CELL; MELANOMA CELL LINE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; MELANOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MELANOMA; STILBENES;

EID: 84916214907     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2716     Document Type: Article

References (31)

1. Chan V, Fenning A, Iver A, et al: Resveratol improves cardiovascular function in DOCA-salt hypertensive rats. Curr Pharm Biotechnol 12: 429-436, 2011.
2. Jiang L, Gu Y, Ye J, Liu F et al: Resveratrol prevents hepatic steatosis induced by hepatitis C virus core protein. Biotechnol Lett 34: 2205-2212, 2012.
3. Zhang F, Liu J and Shi JS. Anti-inflammatory activities of resve-ratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 25: 1-7, 2010.
4. Lin JN, Lin VC, Rau KM, et al: Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem 58: 1584-92, 2010.
5. Huang F, Wu XN, Chen J, et al: Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. Exp Ther Med 7: 1611-1616, 2014.
6. Fulda S: Resveratrol and derivatives for the prevention and treatment of cancer. Drug Discov Today 15: 757-765, 2010.
7. Calabrese EJ, Mattson MP and Calabrese V: Dose response biology: the case of resveratrol. Hum Exp Toxicol 29: 1034-1037, 2010.
8. Park SJ, Ahmad F, Philp A, et al: Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phos-phodiesterases. Cell 148: 421-433, 2012.
9. Bishayee A, Politis T and Darvesh AS: Resveratrol in the chemo-prevention and treatment of hepatocellular carcinoma. Cancer Treat Rev 36: 43-53, 2010.
10. Bishayee A: Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Philia) 2: 409-418, 2009.
11. Hsiao Y P, Yu CS, Yu CC, et al: Triggering apoptotic death of human malignant melanoma a375.s2 cells by bufalin: Involvement of caspase cascade-dependent and independent mitochondrial signaling pathways. Evi Based Complemen Alternat Med 2012: 591241, 2012.
12. Kuo JH, Chu YL, Yang JS, et al: Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria-dependent signal pathways. Int J Oncol 37: 1243-1250, 2010.
13. Vazquez A, Bond EE, Levine AJ and Bond GL: The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 7: 979-987, 2008.
14. Brady CA, Jiang D, Mello SS, et al: Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145: 571-583, 2011.
15. Chee JL, Saidin S, Lane D P, et al: Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9. Cell Cycle 12: 278-288, 2013.
16. Gu H, Rao S, Zhao J, et al: Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells. J Cancer Res Clin Oncol 135: 1777-1782, 2009.
17. Liu B, Zhou Z, Zhou W, et al: Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways. Mol Med Rep 10: 1697-1702, 2014.
18. Li P, Yang S, Dou M, et al: Synergic effects of artemisinin and resveratrol in cancer cells. J Cancer Res Clin Oncol 2014, Epub ahead of print, 2014.
19. Zhang P, Li H, Yang B, et al: Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer 5: 154-64, 2014.
20. Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B and Jäger W: Chemopreventive effects of resveratrol and resveratrol derivatives. Ann NY Acad Sci 1215: 89-95, 2011.
21. Nutakul W, Sobers HS, Qiu P, et al: Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparison. J Agric Food Chem 59: 10964-10970, 2011.
22. Piotrowska H, Kucinska M and Murias M: Biological activity of piceatannol: Leaving the shadow of resveratrol. Mutat Res 750: 60-82, 2012.
23. Um JH, Park SJ, Kang H, et al: AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59: 554-563, 2010.
24. Zhang Y, Liu H, Jin J, Zhu X, Lu L and Jiang H: The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells. Anticancer Drugs 21: 494-501, 2010.
25. Miyata M, Kambe M, Tajima O, et al: Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides. Cancer Sci 102: 2139-2149, 2011.
26. Tasyriq M, Najmuldeen IA, In LL, Mohamad K, Awang K and Hasima N: 7 alpha-Hydroxy-beta-Sitosterol from Chisocheton tomentosus induces apoptosis via dysregulation of cellular Bax/Bcl-2 ratio and cell cycle arrest by downregulating ERK1/2 activation. Evid Based Complement Alternat Med 2012: 765316, 2012.
27. Wu S, Liu B, Zhang Q, et al: Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells. PloS One 8: e76886, 2013.
28. Zhu HB, Yang K, Xie YQ, Lin YW, Mao QQ and Xie LP: Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells. World J Surg Oncology 11: 22, 2013.
29. Yeudall WA, Wrighton KH and Deb S: Mutant p53 in cell adhesion and motility. Methods Mol Biol 962: 135-146, 2013.
30. Voskamp P, Bodmann CA, Koehl GE, et al: Dietary immuno-suppressants do not enhance UV-induced skin carcinogenesis, and reveal discordance between p53-mutant early clones and carcinomas. Cancer Prev Res 6: 129-138, 2013.
31. Lee JH, Gaddameedhi S, Ozturk N, Ye R and Sancar A: DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells. Cancer Res 73: 785-791, 2013.